Vaccinex, Inc.


About Us Executive Team Board of Directors Scientific/ Clinical Advisors Business Strategy Collabora- tions Antibody Technology Overview Membrane Antibody Expression and Selection Secreted IgG Antibody Selection Antibody Animation Development Strategy Development Pipeline


	March 5, 2008 JOHN. E. LEONARD, PH.D., FORMER BIOGEN IDEC ANTIBODY DEVELOPMENT EXECUTIVE, JOINS THE SCIENTIFIC ADVISORY BOARD OF VACCINEX, INC. February 15, 2008 VACCINEX ANTIBODY LICENSED TO GLAXOSMITHKLINE February 13, 2008 VACCINEX ARTICLE IN THE ROCHESTER BUSINESS JOURNAL February 27, 2007 VACCINEX ANNOUNCES ANTIBODY DEVELOPMENT AND COMMERCIALIZATION ALLIANCE IN MULTIPLE SCLEROSIS AND ONCOLOGY November 9, 2006 VACCINEX APPOINTS ROBERT B. PARKER Ph.D AS DIRECTOR, REGULATORY AFFAIRS & QUALITY SYSTEMS October 10, 2006 OPi and VACCINEX ANNOUNCE LICENSE OF FULLY HUMAN ANTI-IL6 ANTIBODY May 23, 2006 VACCINEX, INC. TO PRESENT AT WORLD ANTIBODY SUMMIT February 10, 2006 VACCINEX ANNOUNCES ANTIBODY COLLABORATION WITH SCHERING AG February 15, 2005 VACCINEX NAMES SHAUN MARTIN AS DIRECTOR, PRE-CLINICAL DEVELOPMENT November 18, 2004 VACCINEX AND BIOCON TO CO-DEVELOP ANTIBODY PRODUCTS June 29, 2004 VACCINEX AND OPi ANNOUNCE ANTIBODY COLLABORATION June 3, 2004 VACCINEX RAISES $8.4 MILLION IN PRIVATE FINANCING May 4, 2004 VACCINEX RECEIVES SECOND $2 MILLION ADVANCED TECHNOLOGY AWARD FROM NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY April 21, 2004 VACCINEX AWARDED SBIR GRANT FOR DISCOVERY OF ANTIBODIES AGAINST SMALLPOX March 25, 2004 VACCINEX AND UNIVERSITY OF ROCHESTER ANNOUNCE PATENT AWARD July 11, 2003 LONZA BIOLOGICS AND VACCINEX ANOUNCE STRATEGIC ALLIANCE June 30, 2003 VACCINEX ANNOUNCES TWO NEW BOARD MEMBERS June 13, 2003 VACCINEX CEO TO PRESENT AT BIO 2003 ANNUAL CONVENTION June 10, 2002 VACCINEX, INC. SELECTED TO PRESENT AT BIO 2002 INVESTOR FORUM May 14, 2002 VACCINEX OPENS NEW STATE-OF-THE-ART BIOTECH RESEARCH FACILITY AND CORPORATE HEADQUARTERS April 24, 2002 VACCINEX, INC AWARDED NIH GRANT TO STUDY THE MOLECULAR MECHANISMS INVOLVED IN OSTEOPOROSIS January 29, 2002 VACCINEX, INC. ANNOUNCES NEWLY DESIGNED WEB SITE September 28, 2001 VACCINEX, INC. NAMES R. STANLEY HOLLAND AS VICE PRESIDENT OF FINANCE AND CHIEF FINANCIAL OFFICER August 14, 2001 VACCINEX, INC. NAMES RAYMOND E. WATKINS AS VICE PRESIDENT OF OPERATIONS AND COMPANY OFFICER August 14, 2001 VACCINEX DESCRIBES NEW TECHNOLOGY TO IDENTIFY CANCER TARGETS June 28, 2001 VACCINEX AWARDED GRANT TO STUDY MUSCULOSKELETAL DEVELOPMENT June 28, 2001 VACCINEX RECEIVES NEW YORK STATE GRANT TO TRAIN HIGH-TECH WORKERS June 21, 2001 VACCINEX AWARDED NIH PHASE II GRANT FOR PRE-CLINICAL DEVELOPMENT OF A NOVEL CANCER ANTIGEN June 21, 2001 VACCINEX NAMES ERNEST S. SMITH, Ph.D. RESEARCH DIRECTOR May 15, 2001 GOVERNOR PATAKI ANNOUNCES 78 NEW BIOTECH JOBS IN ROCHESTER September 27, 2000 VACCINEX, L.P. RECEIVES $2 MILLION ADVANCED TECHNOLOGY PROGRAM AWARD Copyright © 2008 Vaccinex, Inc.